Nanoparticle albumin-bound (nab) paclitaxel therapy in patients with primary and recurrent ovarian, fallopian tube, and primary peritoneal carcinoma

Rasool, Nabila

172 - Poster Session A
Nanoparticle albumin-bound (nab) paclitaxel therapy in patients with primary and recurrent ovarian, fallopian tube, and primary peritoneal carcinoma

Saturday, March 22, 2014: 7:25 PM

West Exhibit Hall (Tampa Convention Center)

N. Rasool¹, S. Talukdar², Y. Wang¹, R. K. Hanna¹, T. E. Buekers¹, A. R. Munkarah¹ and S. Hensley Alford¹
¹Henry Ford Health System, Detroit, MI, ²Henry Ford Health Systems, Detroit, MI

45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Navigation

172 - Poster Session A
Nanoparticle albumin-bound (nab) paclitaxel therapy in patients with primary and recurrent ovarian, fallopian tube, and primary peritoneal carcinoma

172 - Poster Session A Nanoparticle albumin-bound (nab) paclitaxel therapy in patients with primary and recurrent ovarian, fallopian tube, and primary peritoneal carcinoma

172 - Poster Session A
Nanoparticle albumin-bound (nab) paclitaxel therapy in patients with primary and recurrent ovarian, fallopian tube, and primary peritoneal carcinoma